Latest Networking News

Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.

Ampol will acquire Evie Networks for $225 million in a debt-funded deal that would more than triple its public charging footprint to approximately 1,425 bays. The transaction offers a faster route into Australia’s expanding EV infrastructure market, but its earnings case depends on regulatory clearance, integration and rising utilisation.

Transurban Group has agreed to pay $4.5 billion for Canada’s pension fund’s stakes in three major Sydney toll roads, lifting its ownership of Westlink M7, NorthConnex and WestConnex. The debt-funded transaction is expected to support long-term free cash growth, but still requires regulatory and contractual approvals.

Elixir Energy has begun the second phase of flow testing at Lorelle-3H after a 60-day reservoir soak, moving the Queensland appraisal well closer to a potential maiden Reserves booking. Success could position the well as a foundation producer for the proposed Warkon Pilot.

Camplify Holdings cut its FY26 net loss by 95% and returned to profit in the second half as cost reductions and MyWay Mutual reshaped the business. The turnaround remains incomplete, with negative operating cash flow, a net current liability position and an auditor’s material uncertainty warning.

Heartland shareholders have overwhelmingly approved the proposed acquisition of TSB and the creation of TSB Heartland Bank, advancing the transaction toward regulatory completion. The deal still faces outstanding conditions, including a Material Adverse Change test and required approvals.

Australian Bond Exchange Holdings improved revenue, reduced its annual loss and sharply cut operating cash outflow in FY2026. Yet with only A$249,000 in cash, net liabilities of A$1.43 million and A$2 million of convertible notes maturing from April 2027, the turnaround remains financially fragile.

Decidr AI Industries delivered 99% revenue growth and a A$13.6 million annualised exit rate in FY26, but the company’s A$32.4 million loss and auditor-highlighted going concern uncertainty put funding at the centre of its next chapter. Management is targeting A$5 million in annualised savings while seeking to convert early AI deployments into recurring revenue.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Botala Energy’s Serowe CBM project has reached its most important testing phase after well 3.5B delivered strong early water production and casing pressure. The operational progress is material, but the company still faces a funding hurdle and has not yet demonstrated sustained commercial gas flow.

Vitrafy has added US blood network Versiti to its cryopreservation development programme, with the partnership focused on no-wash platelet preservation and regulatory verification. The deal strengthens the company’s institutional network, but initially generates no revenue and remains subject to US regulatory requirements.

Atlas Arteria has warned that France may more than double the tax rate applied to eligible toll-road operators, with APRR’s 2025 TEILD bill already reaching €126.7 million. The proposed changes remain subject to parliamentary debate and could be softened before becoming law.